{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:56:20Z","timestamp":1793393780982,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2014\/50928- 2"],"award-info":[{"award-number":["2014\/50928- 2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["465687\/2014-8"],"award-info":[{"award-number":["465687\/2014-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jconrel.2021.08.039","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T22:24:24Z","timestamp":1629757464000},"page":"316-329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["TNF\u03b1 siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy"],"prefix":"10.1016","volume":"338","author":[{"given":"Isabella Luiz","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete Moreno","family":"de Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanderlei Salvador","family":"Bagnato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vitoria Lopes Badra","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.08.039_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122650","article-title":"The immunogenetics of psoriasis and implications for drug repositioning","volume":"18","author":"Xu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122684","article-title":"Molecular mechanisms and management of a cutaneous inflammatory disorder: Psoriasis","volume":"18","author":"Woo","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.21037\/atm.2018.04.09","article-title":"Molecular mechanisms of mechanotransduction in psoriasis","volume":"6","author":"Malakou","year":"2018","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0020","article-title":"C10orf99 contributes to the development of psoriasis by promoting the proliferation of keratinocytes","volume":"8","author":"Chen","year":"2018","journal-title":"Nat. Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0025","article-title":"Using siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation in psoriasis","volume":"28","author":"Nemati","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2016.07.003","article-title":"Advances in psoriasis physiopathology and treatments: up to date of mechanistic insights and perspectives of novel therapies based on innovative skin drug delivery systems (ISDDS)","volume":"239","author":"Sala","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.01549","article-title":"The interplay between keratinocytes and immune cells in the pathogenesis of psoriasis","volume":"9","author":"Albanesi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0040","series-title":"Scanning the Immunopathogenesis of Psoriasis","author":"Chiricozzi","year":"2018"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0045","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1517\/17425247.2010.503953","article-title":"Topical delivery for the treatment of psoriasis","volume":"7","author":"Mitra","year":"2010","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0050","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/09546634.2017.1309349","article-title":"Retinoids: a journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects","volume":"28","author":"Khalil","year":"2017","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112297","article-title":"Old and new biological therapies for psoriasis","volume":"18","author":"R\u00f8nholt","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-018-8668-1","article-title":"Psoriasis: from pathogenesis to targeted therapies","volume":"54","author":"Conrad","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0065","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1517\/14656566.2014.875159","article-title":"New topical treatments for psoriasis","volume":"15","author":"Chiricozzi","year":"2014","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00403-013-1379-9","article-title":"Identifying targets for topical RNAi therapeutics in psoriasis: assessment of a new in vitro psoriasis model","volume":"305","author":"Bracke","year":"2013","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0075","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/exd.13414","article-title":"Towards the development of a RNAi-based topical treatment for psoriasis: proof-of-concept in a 3D psoriasis skin model","volume":"27","author":"Desmet","year":"2018","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0080","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.biopha.2018.07.156","article-title":"Understanding the prospective of nano-formulations towards the treatment of psoriasis","volume":"107","author":"Pradhan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3390\/nano7040077","article-title":"siRNA delivery strategies: A comprehensive review of recent developments","volume":"7","author":"Tatiparti","year":"2017","journal-title":"Nanomaterials"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0090","doi-asserted-by":"crossref","first-page":"48","DOI":"10.59566\/IJBS.2017.13048","article-title":"Molecular mechanisms and biological functions of siRNA","volume":"13","author":"Dana","year":"2017","journal-title":"Int. J. Biomed. Sci."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-017-0450-0","article-title":"Advances in the delivery of RNA therapeutics: from concept to clinical reality","volume":"9","author":"Kaczmarek","year":"2017","journal-title":"Genome Med."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0100","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2013.04.021","article-title":"Topical delivery of anti-TNF \u03b1 siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo","volume":"170","author":"Desai","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0105","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1166\/jbn.2016.2211","article-title":"Liquid crystalline nanodispersions functionalized with cell-penetrating peptides for topical delivery of short-interfering RNAs: a proposal for silencing a pro-inflammatory cytokine in cutaneous diseases","volume":"12","author":"Petrilli","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0110","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2016.12.022","article-title":"Topical and cutaneous delivery using nanosystems","volume":"247","author":"Roberts","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0115","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejps.2017.11.023","article-title":"Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: a review","volume":"112","author":"Garc\u00eas","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.10.046","article-title":"Lipid nanocarriers as skin drug delivery systems: properties, mechanisms of skin interactions and medical applications","volume":"535","author":"Sala","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0125","article-title":"Topical and targeted delivery of siRNAs to melanoma cells using a fusion peptide carrier","volume":"6","author":"Ruan","year":"2016","journal-title":"Nat. Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0130","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ejpb.2008.05.008","article-title":"Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC)","volume":"70","author":"Fang","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0135","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/17425247.2017.1311320","article-title":"Formulation challenges for 21st century topical and transdermal delivery systems","volume":"6","author":"Singhal","year":"2017","journal-title":"Expert. Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0140","first-page":"1","article-title":"Photo-enhanced delivery of genetic material using curcumin loaded composite nanocarriers","volume":"2","author":"Pinnapireddy","year":"2017","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/978-1-60761-697-9_10","article-title":"Photochemical internalization (PCI): a technology for drug delivery","volume":"635","author":"Berg","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0150","series-title":"In Vitro TyRP-1 Knockdown Based on siRNA Carried by Liquid Crystalline Nanodispersions\u202f: An Alternative Approach for Topical Treatment of Vitiligo","author":"Tofani","year":"2018"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejps.2017.09.034","article-title":"Evaluation of critical parameters for in vitro skin permeation and penetration studies using animal skin models","volume":"111","author":"Pra\u00e7a","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0160","series-title":"Guideline for Thetesting of Chemicals: Skin Absorption In Vitro Method","author":"OECD","year":"2004"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0165","series-title":"Guideline for the Testing of Chemicals: Skin Absorption In Vivo Method","author":"OECD","year":"2004"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0170","series-title":"Imiquimod-Induced Psoriasis-like Skin Inflammation in Mice Is Mediated Via the IL-23\/IL-17 Axis","author":"Van Der Fits","year":"2018"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0175","series-title":"Comparison of Normal Versus Imiquimod-Induced Psoriatic Skin in Mice for Penetration of Drugs and Nanoparticles","first-page":"5625","author":"Cun","year":"2018"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2016.05.017","article-title":"Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment","volume":"246","author":"Boakye","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejps.2017.01.031","article-title":"The vector-related influences of autophagic microRNA delivery by Lipofectamine 2000 and polyethylenimine 25K on mouse embryonic fibroblast cells","volume":"101","author":"Lin","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep25879","article-title":"The intracellular trafficking mechanism of Lipofectamine-based transfection reagents and its implication for gene delivery","volume":"6","author":"Cardarelli","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.10.046","article-title":"Lipid nanocarriers as skin drug delivery systems: properties, mechanisms of skin interactions and medical applications","volume":"535","author":"Sala","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0200","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.bbamem.2007.01.013","article-title":"Photochemical internalization enhances silencing of epidermal growth factor receptor through improved endosomal escape of siRNA","volume":"5","author":"Oliveira","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0205","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10555-017-9717-6","article-title":"RNA interference-based therapy and its delivery systems","volume":"1","author":"Chen","year":"2018","journal-title":"Cancer Metastasis."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.10.046","article-title":"Lipid nanocarriers as skin drug delivery systems: properties, mechanisms of skin interactions and medical applications","volume":"535","author":"Sala","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0220","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s10973-018-7072-7","article-title":"Influence of stearic acid and beeswax as solid lipid matrix of lipid nanoparticles containing tacrolimus","volume":"132","author":"Dantas","year":"2018","journal-title":"J. Therm. Anal. Calorim."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0225","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejpb.2012.11.026","article-title":"Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus, part II-in vivo assessment, drug targeting, efficacy, and safety in treatment for atopic dermatitis","volume":"84","author":"Pople","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0230","series-title":"Recent Developments in Nucleic Acid Delivery with Polyethylenimines","author":"Neuberg","year":"2014"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0235","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.msec.2016.07.066","article-title":"Polyethylenimine: a versatile, multifunctional non-viral vector for nucleic acid delivery","volume":"68","author":"Pandey","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0240","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejpb.2013.08.013","article-title":"Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: a review of the state of the art","volume":"86","author":"Weber","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0245","first-page":"1","article-title":"Preparation, characterization and application in drugs and cosmetics of solid lipid nanoparticles","volume":"2","author":"Marcato","year":"2009","journal-title":"Rev. El de Farmacia"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0250","first-page":"1231","article-title":"Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies","volume":"9","author":"Gomes","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0255","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1021\/acs.molpharmaceut.6b01141","article-title":"In situ gelling liquid crystalline system as local siRNA delivery system","volume":"14","author":"Borgheti-Cardoso","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0260","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jconrel.2011.11.014","article-title":"Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers","volume":"161","author":"Scholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0265","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.2174\/1381612823666171122111132","article-title":"Effective delivery routes and strategies for solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC)","volume":"23","author":"Shastri","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0270","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijpharm.2008.10.003","article-title":"Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products","volume":"1-2","author":"Pardeike","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jconrel.2016.07.027","article-title":"Nanocarriers for drug delivery into and through the skin \u2014 do existing technologies match clinical challenges?","volume":"242","author":"Vogt","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0280","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.ymthe.2017.01.024","article-title":"Polyplex evolution: understanding biology, optimizing performance","volume":"25","author":"Hall","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0285","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2017.10.064","article-title":"High payload nanostructured lipid carriers fabricated with alendronate\/polyethyleneimine ion complexes","volume":"535","author":"Abd El-Hamid","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0290","first-page":"23","article-title":"Cytotoxic impacts of linear and branched polyethylenimine nanostructures in A431 cells","volume":"1","author":"Kafil","year":"2011","journal-title":"BioImpacts."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0295","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/jbm.b.33882","article-title":"Comparative study of cytotoxicity and genotoxicity of commercial Jeffamines\u00ae and polyethylenimine in CHO-K1 cells","volume":"106","author":"Castan","year":"2018","journal-title":"J. Biomed. Mater. Res. - Part B Appl. Biomater."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0300","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.1038\/onc.2015.15","article-title":"Design of an EGFR-targeting toxin for photochemical delivery: in vitro and in vivo selectivity and efficacy","volume":"44","author":"Berstad","year":"2015","journal-title":"Oncogene."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0305","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1155\/2014\/921296","article-title":"Enhanced efficacy of Bleomycin in bladder cancer cells by photochemical internalization","volume":"2014","author":"Baglo","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0310","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/lsm.21084","article-title":"Photochemical internalization of tumor-targeted protein toxins","volume":"7","author":"Weyergang","year":"2011","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0315","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.4049\/jimmunol.1302959","article-title":"Interplay between CXCR2 and BLT1 facilitates neutrophil infiltration and resultant keratinocyte activation in a murine model of Imiquimod-induced psoriasis","volume":"192","author":"Sumida","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0320","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejpb.2016.05.012","article-title":"RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase","volume":"105","author":"Depieri","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0325","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jid.2017.09.019","article-title":"How effective is tacrolimus in the imiquimod - induced mouse model of psoriasis?","volume":"138","author":"Pischon","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2021.08.039_bb0330","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ijpharm.2017.06.050","article-title":"Dual roles of TPGS based microemulsion for tacrolimus: enhancing the percutaneous delivery and anti-psoriatic efficacy","volume":"528","author":"Wan","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0335","doi-asserted-by":"crossref","first-page":"18577","DOI":"10.1038\/srep18577","article-title":"The molecular mechanism of photochemical internalization of cell penetrating peptide-cargo-photosensitizer conjugates","volume":"5","author":"Ohtsuki","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0340","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s13346-020-00723-6","article-title":"Nanostructured lipid carrier co-delivering tacrolimus and TNF-\u03b1 siRNA as an innovate approach to psoriasis","volume":"10","author":"Viegas","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0345","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1039\/C6NR08486A","article-title":"Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks","volume":"9","author":"Zhang","year":"2017","journal-title":"Nanoscale."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0350","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s13346-013-0149-8","article-title":"Overcoming the stratum corneum barrier\u202f: a nano approach","volume":"3","author":"Banerjee","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0355","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2016.09.007","article-title":"Improved topical delivery of tacrolimus: a novel composite hydrogel formulation for the treatment of psoriasis","volume":"242","author":"Gabriel","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0360","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ejpb.2010.11.007","article-title":"Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung","volume":"77","author":"G\u00fcnther","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0365","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejpb.2016.05.012","article-title":"RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase","volume":"105","author":"Depieri","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.08.039_bb0370","doi-asserted-by":"crossref","first-page":"325","DOI":"10.31083\/ph.2011.0337","article-title":"Evaluation of physicochemical properties and aggregation of the photosensitizers TPCS2a and TPPS2a in aqueous media","volume":"66","author":"Lilletvedt","year":"2011","journal-title":"Pharmazie"},{"key":"10.1016\/j.jconrel.2021.08.039_bb0375","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10103-017-2360-1","article-title":"A clinical review of phototherapy for psoriasis","volume":"33","author":"Zhang","year":"2018","journal-title":"Lasers Med. Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921004454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921004454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:40:30Z","timestamp":1777509630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921004454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":75,"alternative-id":["S0168365921004454"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.08.039","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNF\u03b1 siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.08.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}